Clinical Trials Directory

Trials / Unknown

UnknownNCT02847312

Chronic Cardiovascular and Gut-bacteria Effects of Phenolic Rich Oats in Adults With Above Average Blood Pressure

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Reading · Academic / Other
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Accepted

Summary

In this proposed human trial, the investigators aim to establish whether 4 weeks of daily consumption of beta-glucan matched meals providing either a high dose or a moderate dose of oat avenanthramides and phenolic acids leads to dose-dependent chronic improvements in markers of CVD risk and gut health relative to an energy matched control intervention in healthy adults with above average blood pressure.

Detailed description

* To investigate the chronic effects of daily intake of oat products on flow mediated dilatation of the brachial artery (FMD; primary endpoint), microvascular endothelial function (measured by laser Doppler iontophoresis), pulse wave analysis, gut microbiota diversity, 24h blood pressure, activity of the renin angiotensin system, markers related to cellular production of nitric oxide and reactive oxygen species, inflammatory cytokines, and further potentially emerging biochemical markers of CVD risk. * To establish if phenolic acids and avenanthramides from oat products exert cardiovascular and microbial effects in a dose dependent manner. * To measure urinary and fecal excretion of avenanthramide and phenolic acid metabolites. To explore correlations between bacterial population changes and CVD risk markers.

Conditions

Interventions

TypeNameDescription
OTHERHigh avenanthramide, phenolic acidHigh avenanthramide and high phenolic acid, matched with energy and insoluable fibre.
OTHERLow avenanthramide, medium phenolic acidLow avenanthramide and moderate phenolic acid, matched with energy and insoluable fibre.
OTHERControlControl are matched with energy and insoluable fibre.

Timeline

Start date
2016-07-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-07-28
Last updated
2016-07-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02847312. Inclusion in this directory is not an endorsement.